MENU
VRTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Vertex Pharmaceuticals (VRTX) Ownership - Who owns Vertex Pharmaceuticals?
Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
50 Northern Avenue
Phone
+1 617 341-6100
Employees
5400
Web
https://www.vrtx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
113.32B
P/E Ratio
32.76
Total Cash
6.2B
Projected Growth
2.74
Total Debt
1.65B
Revenue
11.1B
Risk (Beta)
0.35
Dividend Yield
N/A
Total Cash/Share
24.15
Total Debt/Equity
43.97
Revenue/Share
43.09 USD as % of share price
Fundamentals
VRTX
Capitalization
113B
P/E Ratio
32.76
Risk (Beta)
0.35
Dividend Yield
N/A
Total Cash
6.2B
Total Cash/Share
24.15
Total Debt
1.65B
Total Debt/Equity
43.97
Projected Growth (PEG Ratio)
2.74
Revenue/Share (as % of the share price)
43.09%
Revenue
11.1B
ROE
N/A
Book Value
16.5B
P/B Ratio
6.87
Cash Flow
N/A
Earnings
-3.82
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2.6M
Current Ratio
2.65
Current Revenue Per Employee
454131.16
Dividends Per Share - Security
N/A
EBITDA
-74.9M
Float
N/A
Float - Current
N/A
Gross Income Margin
86.90
Revenue To Assets
-4.23
Shares Held By Institutions
418B
Shares Outstanding - Current
257M
Total Liabilities
6.38B
Total Volume MTD
N/A
Value
-1
Gain YTD
9.585
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a company that discovers and develops novel, small molecule pharmaceuticals
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
50 Northern Avenue
Phone
+1 617 341-6100
Employees
5400
Web
https://www.vrtx.com